Page 8 - Johnson & Johnson

Britain lines up more potential Covid-19 vaccines with J&J, Novavax deals

Britain and the United States are in the lead with six vaccine deals with drugmakers each, as companies and governments worldwide work overtime to find a vaccine against the pandemic disease

Hyderabad-based Biological E joins hands with J&J for Covid-19 vaccine

The vaccine candidate is in phase 1/2a clinical trials

US inks $1.5 bn deal with Moderna for 100 mn doses of Covid-19 'vaccine'

The US government previously gave Moderna around $1 billion to fund its research efforts, bringing total US funding to around $2.5 billion

Johnson & Johnson's Covid-19 vaccine protected monkey in single shot

A leading candidate of Covid-19 vaccine developed by global healthcare company Johnson & Johnson raised neutralising antibodies and robustly protected monkeys against SARS-CoV-2, the virus that causes Covid-19.

Emergent signs 5-year deal to make drug used in J&J's Covid-19 vaccine

The news follows a $135 million deal struck by the two companies in April, to use Emergent's manufacturing facilities to speed up the development and production of its vaccine candidate

J&J loses bid to overturn baby powder verdict, but damages cut to $2.12 bn

The Missouri Court of Appeals lowered the original $4.69 billion verdict from July 2018 after dismissing claims by some of the 22 women and their families who had sued

J&J sets aside fairness business to stand with #BlackLivesMatter movement

Now with J&J taking its brand out of the game, other brands have a larger slice of the pie to carve out, but is there a risk in doing that?

J&J to begin human trials of Covid-19 vaccine in second half of July

The company has already signed deals with the US government to create enough manufacturing capacity to produce more than 1 billion doses of its vaccine through 2021

Johnson & Johnson to stop selling talc-based baby powder in US, Canada

J&J faces about 19,400 cases alleging its talcum powder caused users to develop ovarian cancer, through use for feminine hygiene, or mesothelioma, a cancer that strikes the lungs and other organs

J&J to stop selling baby powder in US, Canada after portfolio reassessment

J&J faces more than 16,000 lawsuits from consumers claiming its talc products, including Johnson's Baby Powder, caused their cancer

Johnson & Johnson expects human trial of its Covid-19 vaccine by September

Through a partnership, the Biomedical Advanced Research and Development Authority (BARDA) and Johnson & Johnson together have committed more than $1 billion of investment to co-fund vaccine research

Johnson & Johnson says no evidence of HIV drug working against Coronavirus

The company said it was aware that HIV treatments are being considered as options to treat patients diagnosed with COVID-19, a disease caused by the coronavirus

J&J sees high demand for consumer products as Coronavirus spreads

J&J said majority of its global medical device manufacturing was running at or near normal capacity, and that it does not expect the outbreak to cause any disruptions to its supply of medicines.

J&J ordered by Florida jury to pay $9 million in talc-cancer case

The talc litigation may eventually cost the company as much as $10 billion, according to Bloomberg Intelligence

S P Jain Global bags 50% international offers, top offer at Rs 45 lakh

Consulting emerges as top recruiting sector, with 24% placement offers, followed by logistics & supply chain at 17%, and IT at 16%

J&J's own expert working for FDA found asbestos in baby powder sample

(Reuters) - Ever since Johnson & Johnson disclosed this month that a government test had turned up asbestos in its Baby Powder, the company has attacked the validity of the result.

Johnson & Johnson to expand its anti-TB programme in India

Programme aims to broaden access to treatment for multidrug-resistant strain, improve detection, build critical health systems, and raise awareness about TB at community level

J&J asked to pay $8 billion over side effects of antipsychotic drug

NEW YORK (Reuters) - Johnson & Johnson must pay $8 billion (6.6 billion pounds) in punitive damages to a man who previously won $680,000 over his claims that it failed to warn that young men using its antipsychotic drug Risperdal could grow breasts, a Philadelphia jury said on Tuesday.

US judge fines Johnson & Johnson $572 mn for fuelling opioid epidemic

(Reuters) - An Oklahoma judge on Monday found Johnson & Johnson liable for fuelling an opioid epidemic in the state by deceptively marketing painkillers, and ordered the drugmaker to pay damages of $572 million.

J&J pays Rs 25 lakh each to three victims in UP for faulty hip implants

Pharmaceutical Major Johnson & Johnson said it has paid Rs 25 lakh each to three victims of its faulty acetabular surface replacement (ASR) hip implants in Uttar Pradesh. According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone revision surgeries for the faulty implants made by the company. The Delhi High Court had in May directed Johnson and Johnson to make an interim payment of Rs 25 lakh each to the 67 patients who have undergone revision surgeries. Jain said the Uttar Pradesh Drug Licensing and Control Authority was promptly following such complaints.